NCT00513864View on ClinicalTrials.gov

Assessment of Opioid Analgesia in Sickle Cell

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2006

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Sickle Cell Disease
Interventions
DRUG

Dextromethorphan

one time dose - 0.3mg/kg PO

DRUG

Codeine

one time dose - 2mg/kg PO

DRUG

Morphine

one time dose - 0.15mg/kg IV

Trial Locations (1)

20010

Children's National Medical Center, Washington D.C.

Sponsors
All Listed Sponsors
lead

Children's National Research Institute

OTHER